Key result
Subclinical valve thrombosis is increasingly recognized after TAVR, but long-term clinical impact remains unclear.
Why the study?
Recent studies suggest patients can develop subclinical transcatheter heart valve thrombosis after TAVR, which can precede leaflet dysfunction despite first-line antiplatelet therapy.
Subclinical transcatheter heart valve thrombosis is increasingly recognized post-TAVR, with MDCT being more sensitive than echocardiography for detection, though its long-term clinical impact on valve durability remains unclear.
No change to post-TAVR antithrombotic strategies warranted; leaves open long-term effects on durability and thromboembolism.
Transcatheter aortic valve replacement (TAVR) has grown exponentially worldwide in the last decade. Due to the higher bleeding risks associated with oral anticoagulation and in patients undergoing TAVR, antiplatelet therapy is currently considered first-line antithrombotic treatment after TAVR. Recent studies suggest that some patients can develop subclinical transcatheter heart valve (THV) thrombosis after the procedure, whereby thrombus forms on the leaflets that can be a precursor to leaflet dysfunction. Compared with echocardiography, multidetector computed tomography is more sensitive at detecting THV thrombosis. Transcatheter heart valve thrombosis can occur while on dual antiplatelet therapy with aspirin and thienopyridine but significantly less with anticoagulation. This review summarizes the incidence and diagnostic criteria for THV thrombosis and discusses the pathophysiological mechanisms that may lead to thrombus formation, its natural history, potential clinical implications and treatment for these patients.
No takes yet. Share an insight, caveat, or question.
Ng et al. (2020) conducted a review in Transcatheter heart valve thrombosis. Transcatheter aortic valve replacement (TAVR) was evaluated. Subclinical transcatheter heart valve thrombosis is increasingly recognized after TAVR, though its long-term clinical implications on valve durability and thromboembolism remain unclear.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: